ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parkinson Disease Drug Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-39X2260
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Parkinson Disease Drug Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Parkinson Disease Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-39X2260
Report
July 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
AbbVie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health

Parkinson Disease Drug Market Size

The global Parkinson Disease Drug market is projected to grow from US$ 5866 million in 2024 to US$ 8397.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.

Parkinson Disease Drug Market

Parkinson Disease Drug Market

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
Market Analysis and Insights: Global Parkinson Disease Drug Market
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
Report Covers:
This report presents an overview of global market for Parkinson Disease Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Parkinson Disease Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Parkinson Disease Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Parkinson Disease Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Parkinson Disease Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Parkinson Disease Drug revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Parkinson Disease Drug Market Report

Report Metric Details
Report Name Parkinson Disease Drug Market
Accounted market size in 2024 US$ 5866 million
Forecasted market size in 2030 US$ 8397.5 million
CAGR 6.2
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Sinemet-CR
  • Trastal
  • Madopar
  • COMT Inhibitor
  • Other
Segment by Application
  • Under 40 Years Old
  • 40-65 Years Old
  • Above 65 Years Old
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Parkinson Disease Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Parkinson Disease Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parkinson Disease Drug revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Parkinson Disease Drug Market growing?

Ans: The Parkinson Disease Drug Market witnessing a CAGR of 6.2 during the forecast period 2024-2030.

What is the Parkinson Disease Drug Market size in 2030?

Ans: The Parkinson Disease Drug Market size in 2030 will be US$ 8397.5 million.

Who are the main players in the Parkinson Disease Drug Market report?

Ans: The main players in the Parkinson Disease Drug Market are Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Desitin Arzneimittel, Endo Pharmaceuticals, F.Hoffmann-La Roche, H.Lundbeck, Valeant, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Bausch Health

What are the Application segmentation covered in the Parkinson Disease Drug Market report?

Ans: The Applications covered in the Parkinson Disease Drug Market report are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

What are the Type segmentation covered in the Parkinson Disease Drug Market report?

Ans: The Types covered in the Parkinson Disease Drug Market report are Sinemet-CR, Trastal, Madopar, COMT Inhibitor, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson Disease Drug Market Perspective (2019-2030)
2.2 Global Parkinson Disease Drug Growth Trends by Region
2.2.1 Parkinson Disease Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parkinson Disease Drug Historic Market Size by Region (2019-2024)
2.2.3 Parkinson Disease Drug Forecasted Market Size by Region (2025-2030)
2.3 Parkinson Disease Drug Market Dynamics
2.3.1 Parkinson Disease Drug Industry Trends
2.3.2 Parkinson Disease Drug Market Drivers
2.3.3 Parkinson Disease Drug Market Challenges
2.3.4 Parkinson Disease Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Parkinson Disease Drug by Players
3.1.1 Global Parkinson Disease Drug Revenue by Players (2019-2024)
3.1.2 Global Parkinson Disease Drug Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Parkinson Disease Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Parkinson Disease Drug Market Concentration Ratio
3.4.1 Global Parkinson Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Disease Drug Revenue in 2023
3.5 Global Key Players of Parkinson Disease Drug Head office and Area Served
3.6 Global Key Players of Parkinson Disease Drug, Product and Application
3.7 Global Key Players of Parkinson Disease Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson Disease Drug Breakdown Data by Type
4.1 Global Parkinson Disease Drug Historic Market Size by Type (2019-2024)
4.2 Global Parkinson Disease Drug Forecasted Market Size by Type (2025-2030)
5 Parkinson Disease Drug Breakdown Data by Application
5.1 Global Parkinson Disease Drug Historic Market Size by Application (2019-2024)
5.2 Global Parkinson Disease Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parkinson Disease Drug Market Size (2019-2030)
6.2 North America Parkinson Disease Drug Market Size by Type
6.2.1 North America Parkinson Disease Drug Market Size by Type (2019-2024)
6.2.2 North America Parkinson Disease Drug Market Size by Type (2025-2030)
6.2.3 North America Parkinson Disease Drug Market Share by Type (2019-2030)
6.3 North America Parkinson Disease Drug Market Size by Application
6.3.1 North America Parkinson Disease Drug Market Size by Application (2019-2024)
6.3.2 North America Parkinson Disease Drug Market Size by Application (2025-2030)
6.3.3 North America Parkinson Disease Drug Market Share by Application (2019-2030)
6.4 North America Parkinson Disease Drug Market Size by Country
6.4.1 North America Parkinson Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Parkinson Disease Drug Market Size by Country (2019-2024)
6.4.3 North America Parkinson Disease Drug Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Parkinson Disease Drug Market Size (2019-2030)
7.2 Europe Parkinson Disease Drug Market Size by Type
7.2.1 Europe Parkinson Disease Drug Market Size by Type (2019-2024)
7.2.2 Europe Parkinson Disease Drug Market Size by Type (2025-2030)
7.2.3 Europe Parkinson Disease Drug Market Share by Type (2019-2030)
7.3 Europe Parkinson Disease Drug Market Size by Application
7.3.1 Europe Parkinson Disease Drug Market Size by Application (2019-2024)
7.3.2 Europe Parkinson Disease Drug Market Size by Application (2025-2030)
7.3.3 Europe Parkinson Disease Drug Market Share by Application (2019-2030)
7.4 Europe Parkinson Disease Drug Market Size by Country
7.4.1 Europe Parkinson Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Parkinson Disease Drug Market Size by Country (2019-2024)
7.4.3 Europe Parkinson Disease Drug Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Parkinson Disease Drug Market Size (2019-2030)
8.2 China Parkinson Disease Drug Market Size by Type
8.2.1 China Parkinson Disease Drug Market Size by Type (2019-2024)
8.2.2 China Parkinson Disease Drug Market Size by Type (2025-2030)
8.2.3 China Parkinson Disease Drug Market Share by Type (2019-2030)
8.3 China Parkinson Disease Drug Market Size by Application
8.3.1 China Parkinson Disease Drug Market Size by Application (2019-2024)
8.3.2 China Parkinson Disease Drug Market Size by Application (2025-2030)
8.3.3 China Parkinson Disease Drug Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Parkinson Disease Drug Market Size (2019-2030)
9.2 Asia Parkinson Disease Drug Market Size by Type
9.2.1 Asia Parkinson Disease Drug Market Size by Type (2019-2024)
9.2.2 Asia Parkinson Disease Drug Market Size by Type (2025-2030)
9.2.3 Asia Parkinson Disease Drug Market Share by Type (2019-2030)
9.3 Asia Parkinson Disease Drug Market Size by Application
9.3.1 Asia Parkinson Disease Drug Market Size by Application (2019-2024)
9.3.2 Asia Parkinson Disease Drug Market Size by Application (2025-2030)
9.3.3 Asia Parkinson Disease Drug Market Share by Application (2019-2030)
9.4 Asia Parkinson Disease Drug Market Size by Region
9.4.1 Asia Parkinson Disease Drug Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Parkinson Disease Drug Market Size by Region (2019-2024)
9.4.3 Asia Parkinson Disease Drug Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Parkinson Disease Drug Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Parkinson Disease Drug Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Disease Drug Introduction
11.1.4 Merck Revenue in Parkinson Disease Drug Business (2019-2024)
11.1.5 Merck Recent Developments
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Disease Drug Introduction
11.2.4 Akorn Revenue in Parkinson Disease Drug Business (2019-2024)
11.2.5 Akorn Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Disease Drug Introduction
11.3.4 GSK Revenue in Parkinson Disease Drug Business (2019-2024)
11.3.5 GSK Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Disease Drug Introduction
11.4.4 Novartis Revenue in Parkinson Disease Drug Business (2019-2024)
11.4.5 Novartis Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2019-2024)
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Disease Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Disease Drug Business (2019-2024)
11.7.5 Abbvie Recent Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2019-2024)
11.8.5 Kyowa Hakko Kirin Pharma Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Disease Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Disease Drug Business (2019-2024)
11.9.5 Astellas Pharma Recent Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024)
11.10.5 Desitin Arzneimittel Recent Developments
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Disease Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2019-2024)
11.11.5 Endo Pharmaceuticals Recent Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2019-2024)
11.12.5 F.Hoffmann-La Roche Recent Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Details
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Disease Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Disease Drug Business (2019-2024)
11.13.5 H.Lundbeck Recent Developments
11.14 Valeant
11.14.1 Valeant Company Details
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Disease Drug Introduction
11.14.4 Valeant Revenue in Parkinson Disease Drug Business (2019-2024)
11.14.5 Valeant Recent Developments
11.15 Apokyn
11.15.1 Apokyn Company Details
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Disease Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Disease Drug Business (2019-2024)
11.15.5 Apokyn Recent Developments
11.16 Orion
11.16.1 Orion Company Details
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Disease Drug Introduction
11.16.4 Orion Revenue in Parkinson Disease Drug Business (2019-2024)
11.16.5 Orion Recent Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Details
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Disease Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024)
11.17.5 Stada Arzneimittel Recent Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Company Details
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Disease Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Disease Drug Business (2019-2024)
11.18.5 US WorldMeds Recent Developments
11.19 Bausch Health
11.19.1 Bausch Health Company Details
11.19.2 Bausch Health Business Overview
11.19.3 Bausch Health Parkinson Disease Drug Introduction
11.19.4 Bausch Health Revenue in Parkinson Disease Drug Business (2019-2024)
11.19.5 Bausch Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
AbbVie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
List of Tables
    Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Sinemet-CR
    Table 3. Key Players of Trastal
    Table 4. Key Players of Madopar
    Table 5. Key Players of COMT Inhibitor
    Table 6. Key Players of Other
    Table 7. Global Parkinson Disease Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Parkinson Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Parkinson Disease Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Parkinson Disease Drug Market Share by Region (2019-2024)
    Table 11. Global Parkinson Disease Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Parkinson Disease Drug Market Share by Region (2025-2030)
    Table 13. Parkinson Disease Drug Market Trends
    Table 14. Parkinson Disease Drug Market Drivers
    Table 15. Parkinson Disease Drug Market Challenges
    Table 16. Parkinson Disease Drug Market Restraints
    Table 17. Global Parkinson Disease Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Parkinson Disease Drug Revenue Share by Players (2019-2024)
    Table 19. Global Top Parkinson Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2023)
    Table 20. Global Parkinson Disease Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Parkinson Disease Drug, Headquarters and Area Served
    Table 23. Global Key Players of Parkinson Disease Drug, Product and Application
    Table 24. Global Key Players of Parkinson Disease Drug, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2019-2024)
    Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2025-2030)
    Table 30. Global Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Parkinson Disease Drug Revenue Share by Application (2019-2024)
    Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Parkinson Disease Drug Revenue Share by Application (2025-2030)
    Table 34. North America Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Parkinson Disease Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Parkinson Disease Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Parkinson Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Parkinson Disease Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Parkinson Disease Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Parkinson Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Parkinson Disease Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Parkinson Disease Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Parkinson Disease Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Parkinson Disease Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Parkinson Disease Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Parkinson Disease Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Parkinson Disease Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Parkinson Disease Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Merck Company Details
    Table 67. Merck Business Overview
    Table 68. Merck Parkinson Disease Drug Product
    Table 69. Merck Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 70. Merck Recent Developments
    Table 71. Akorn Company Details
    Table 72. Akorn Business Overview
    Table 73. Akorn Parkinson Disease Drug Product
    Table 74. Akorn Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 75. Akorn Recent Developments
    Table 76. GSK Company Details
    Table 77. GSK Business Overview
    Table 78. GSK Parkinson Disease Drug Product
    Table 79. GSK Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 80. GSK Recent Developments
    Table 81. Novartis Company Details
    Table 82. Novartis Business Overview
    Table 83. Novartis Parkinson Disease Drug Product
    Table 84. Novartis Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 85. Novartis Recent Developments
    Table 86. Boehringer Ingelheim Company Details
    Table 87. Boehringer Ingelheim Business Overview
    Table 88. Boehringer Ingelheim Parkinson Disease Drug Product
    Table 89. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 90. Boehringer Ingelheim Recent Developments
    Table 91. Teva Pharmaceutical Company Details
    Table 92. Teva Pharmaceutical Business Overview
    Table 93. Teva Pharmaceutical Parkinson Disease Drug Product
    Table 94. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 95. Teva Pharmaceutical Recent Developments
    Table 96. Abbvie Company Details
    Table 97. Abbvie Business Overview
    Table 98. Abbvie Parkinson Disease Drug Product
    Table 99. Abbvie Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 100. Abbvie Recent Developments
    Table 101. Kyowa Hakko Kirin Pharma Company Details
    Table 102. Kyowa Hakko Kirin Pharma Business Overview
    Table 103. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
    Table 104. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 105. Kyowa Hakko Kirin Pharma Recent Developments
    Table 106. Astellas Pharma Company Details
    Table 107. Astellas Pharma Business Overview
    Table 108. Astellas Pharma Parkinson Disease Drug Product
    Table 109. Astellas Pharma Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 110. Astellas Pharma Recent Developments
    Table 111. Desitin Arzneimittel Company Details
    Table 112. Desitin Arzneimittel Business Overview
    Table 113. Desitin Arzneimittel Parkinson Disease Drug Product
    Table 114. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 115. Desitin Arzneimittel Recent Developments
    Table 116. Endo Pharmaceuticals Company Details
    Table 117. Endo Pharmaceuticals Business Overview
    Table 118. Endo Pharmaceuticals Parkinson Disease Drug Product
    Table 119. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 120. Endo Pharmaceuticals Recent Developments
    Table 121. F.Hoffmann-La Roche Company Details
    Table 122. F.Hoffmann-La Roche Business Overview
    Table 123. F.Hoffmann-La Roche Parkinson Disease Drug Product
    Table 124. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 125. F.Hoffmann-La Roche Recent Developments
    Table 126. H.Lundbeck Company Details
    Table 127. H.Lundbeck Business Overview
    Table 128. H.Lundbeck Parkinson Disease Drug Product
    Table 129. H.Lundbeck Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 130. H.Lundbeck Recent Developments
    Table 131. Valeant Company Details
    Table 132. Valeant Business Overview
    Table 133. Valeant Parkinson Disease Drug Product
    Table 134. Valeant Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 135. Valeant Recent Developments
    Table 136. Apokyn Company Details
    Table 137. Apokyn Business Overview
    Table 138. Apokyn Parkinson Disease Drug Product
    Table 139. Apokyn Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 140. Apokyn Recent Developments
    Table 141. Orion Company Details
    Table 142. Orion Business Overview
    Table 143. Orion Parkinson Disease Drug Product
    Table 144. Orion Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 145. Orion Recent Developments
    Table 146. Stada Arzneimittel Company Details
    Table 147. Stada Arzneimittel Business Overview
    Table 148. Stada Arzneimittel Parkinson Disease Drug Product
    Table 149. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 150. Stada Arzneimittel Recent Developments
    Table 151. US WorldMeds Company Details
    Table 152. US WorldMeds Business Overview
    Table 153. US WorldMeds Parkinson Disease Drug Product
    Table 154. US WorldMeds Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 155. US WorldMeds Recent Developments
    Table 156. Bausch Health Company Details
    Table 157. Bausch Health Business Overview
    Table 158. Bausch Health Parkinson Disease Drug Product
    Table 159. Bausch Health Revenue in Parkinson Disease Drug Business (2019-2024) & (US$ Million)
    Table 160. Bausch Health Recent Developments
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson Disease Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Parkinson Disease Drug Market Share by Type: 2023 VS 2030
    Figure 3. Sinemet-CR Features
    Figure 4. Trastal Features
    Figure 5. Madopar Features
    Figure 6. COMT Inhibitor Features
    Figure 7. Other Features
    Figure 8. Global Parkinson Disease Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Parkinson Disease Drug Market Share by Application: 2023 VS 2030
    Figure 10. Under 40 Years Old Case Studies
    Figure 11. 40-65 Years Old Case Studies
    Figure 12. Above 65 Years Old Case Studies
    Figure 13. Parkinson Disease Drug Report Years Considered
    Figure 14. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Parkinson Disease Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Parkinson Disease Drug Market Share by Region: 2023 VS 2030
    Figure 17. Global Parkinson Disease Drug Market Share by Players in 2023
    Figure 18. Global Top Parkinson Disease Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Disease Drug as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2023
    Figure 20. North America Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Parkinson Disease Drug Market Share by Type (2019-2030)
    Figure 22. North America Parkinson Disease Drug Market Share by Application (2019-2030)
    Figure 23. North America Parkinson Disease Drug Market Share by Country (2019-2030)
    Figure 24. United States Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Parkinson Disease Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Parkinson Disease Drug Market Share by Type (2019-2030)
    Figure 28. Europe Parkinson Disease Drug Market Share by Application (2019-2030)
    Figure 29. Europe Parkinson Disease Drug Market Share by Country (2019-2030)
    Figure 30. Germany Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Parkinson Disease Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Parkinson Disease Drug Market Share by Type (2019-2030)
    Figure 38. China Parkinson Disease Drug Market Share by Application (2019-2030)
    Figure 39. Asia Parkinson Disease Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Parkinson Disease Drug Market Share by Type (2019-2030)
    Figure 41. Asia Parkinson Disease Drug Market Share by Application (2019-2030)
    Figure 42. Asia Parkinson Disease Drug Market Share by Region (2019-2030)
    Figure 43. Japan Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Parkinson Disease Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Parkinson Disease Drug Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Parkinson Disease Drug Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Parkinson Disease Drug Market Share by Country (2019-2030)
    Figure 53. Brazil Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Parkinson Disease Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 60. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 61. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 64. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 65. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 66. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 67. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 68. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 69. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 70. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 71. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 72. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 73. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 74. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 75. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 76. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 77. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions